This 2022 review by Vukojević et al. explores the neuroprotective and neuromodulatory effects of BPC 157, a stable gastric pentadecapeptide, on the central nervous system (CNS). The authors discuss preclinical studies demonstrating BPC 157's efficacy in various CNS disorders, including traumatic brain injury, stroke, spinal cord injury, and neuropsychiatric conditions.
